يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: Experience of the Italian biologics registries

    المؤلفون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    المساهمون: Codullo, Veronica, Iannone, Florenzo, Sinigaglia, Luigi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni, Caporali, Roberto

    مصطلحات موضوعية: Adalimumab, HAQ, Remission, Rheumatoid arthriti, Rheumatology, Immunology and Allergy, Immunology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28516879; info:eu-repo/semantics/altIdentifier/wos/WOS:000406877800015; volume:35; issue:4; firstpage:660; lastpage:665; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11586/219636Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028659468; http://www.clinexprheumatol.org/article.asp?a=10987Test

    الإتاحة: http://hdl.handle.net/11586/219636Test
    http://www.clinexprheumatol.org/article.asp?a=10987Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)

    المؤلفون: IANNONE, Florenzo, LAPADULA, Giovanni, Ferraccioli, Gianfranco, Gremese, Elisa

    المساهمون: Iannone, Florenzo, Ferraccioli, Gianfranco, Gremese, Elisa, Lapadula, Giovanni

    مصطلحات موضوعية: Anti-TNF, Rheumatoid Arthriti, TNF-alpha, Adalimumab, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Etanercept, Human, Immunoglobulin G, Infliximab, Medication Adherence, Receptors, Tumor Necrosis Factor, Tumor Necrosis Factor-alpha, Rheumatology, Immunology, Biochemistry, Genetics and Molecular Biology (all), Immunology and Allergy

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000335362100002; volume:73; issue:6; firstpage:e31; lastpage:e31; journal:ANNALS OF THE RHEUMATIC DISEASES; http://hdl.handle.net/11586/146506Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84899917627; http://ard.bmj.com/content/73/6/e31.full.pdf+htmlTest

    الإتاحة: https://doi.org/10.1136/annrheumdis-2013-205011Test
    http://hdl.handle.net/11586/146506Test
    http://ard.bmj.com/content/73/6/e31.full.pdf+htmlTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Registry: An Appraisal of Predictors

    المؤلفون: Iannone, Florenzo, Gremese, Elisa, Atzeni, Fabiola, Biasi, Domenico, Botsios, Costantino, Cipriani, Paola, Ferri, Clodoveo, Foschi, Valentina, Galeazzi, Mauro, Gerli, Roberto, Giardina, Annarita, Marchesoni, Antonio, Salaffi, Fausto, Ziglioli, Tamara, Lapadula, Giovanni, Bambara, Maria Lisa, Cantini, Fabrizio, Ferraccioli, Gianfranco, Foti, Rosario, Giacomelli, Roberto, Gorla, Roberto, Grassi, Walter, Mathieu, Alessandro, Olivieri, Ignazio, Passiu, Giuseppe, Punzi, Leonardo, Salvarani, Carlo, Sarzi-Puttini, Piercarlo, Scarpa, Raffaele, Triolo, Giovanni, Trotta, Francesco

    المساهمون: Iannone, F, Gremese, E, Atzeni, F, Biasi, D, Botsios, C, Cipriani, P, Ferri, C, Foschi, V, Galeazzi, M, Gerli, R, Giardina, A, Marchesoni, A, Salaffi, F, Ziglioli, T, Lapadula, G, Scarpa, Raffaele, Gruppo Italiano di Studio sulle Early, Arthritides

    مصطلحات موضوعية: Male, Time Factors, Health Status, Arthritis, Kaplan-Meier Estimate, Receptors, Tumor Necrosis Factor, Etanercept, law.invention, Arthritis, Rheumatoid, Randomized controlled trial, law, Rheumatoid, Monoclonal, Receptors, Immunology and Allergy, Prospective Studies, Registries, skin and connective tissue diseases, Prospective cohort study, Humanized, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthralgia, Biological Markers, Drug Substitution, Female, Humans, Immunoglobulin G, Italy, Joints, Middle Aged, Pain Measurement, Survival Rate, Tumor Necrosis Factor-alpha, Adalimumab, Biomarkers, Infliximab, Rheumatoid arthritis, Drug survival, Rheumatology, Immunology, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Antibodies, Internal medicine, medicine, Survival rate, business.industry, medicine.disease, Surgery, business, Tumor Necrosis Factor

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::983fd14475819ee8f42f44d66d420be9Test
    http://hdl.handle.net/11577/2495602Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث